% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

plagioclase2002 1 post  |  Last Activity: Jun 7, 2015 3:27 PM Member since: May 13, 2003
  • Reply to

    Verastem Webcast

    by kaizen1950 Jun 3, 2015 11:42 AM
    plagioclase2002 plagioclase2002 Jun 7, 2015 3:27 PM Flag

    The interesting session was Sunday 5/31. As Dr. Wicha has been involved in csc research for a long time his remarks were particularly interesting. Immunotherapies will need to be combined with csc therapies. His comments on the importance of FAK inhibitors position as a key mode. Not new , the addition of csc by some oncology drugs. A lot going on.

2.06+0.08(+4.04%)Aug 28 4:00 PMEDT